Not applicableEnded earlyNCT04810949What this trial is testingVitamine D3 Supplementation in Patients With Serum Values +/- 20ng/mlWho this might be right forCovid19Influenza AInfluenza B+1 more Hospital Clinica Nova 41
Not applicableStudy completedNCT01203527What this trial is testingThe Pharmacology of Tamiflu in PregnancyWho this might be right forH1N1 Influenza Treatment During Pregnancy Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 63
Early research (Phase 1)Study completedNCT02014870What this trial is testingSafety and Reactogenicity of a H1N1 Influenza Challenge Virus in Healthy VolunteersWho this might be right forInfluenza A Immune Targeting Systems Ltd 29
Testing effectiveness (Phase 2)Study completedNCT00985088What this trial is testingSafety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and OlderWho this might be right forInfluenza GlaxoSmithKline 1,343
Not applicableUnknownNCT01277380What this trial is testingAnalysis of the Results From Influenza Rapid Test A Positive and H1N1 Real Time RT-PCRWho this might be right forH1N1 Influenza Virus Taipei Medical University WanFang Hospital 100
Not applicableStudy completedNCT01715792What this trial is testingAssess the Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix™ in UKWho this might be right forInfluenza GlaxoSmithKline 587
Large-scale testing (Phase 3)Study completedNCT06087640What this trial is testingA Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of AgeWho this might be right forInfluenza, Human Seqirus 38,769
Not applicableStudy completedNCT01056185What this trial is testingRespiratory Virus Hospitalization Study (FLU 003 Plus)Who this might be right forInfluenzaNovel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV)Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) University of Minnesota 1,000
Large-scale testing (Phase 3)Study completedNCT00971425What this trial is testingEvaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)Who this might be right forInfluenza GlaxoSmithKline 145
Testing effectiveness (Phase 2)Study completedNCT00956046What this trial is testingSwine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 MonthsWho this might be right forInfluenzaSwine-origin A/H1N1 Influenza Sanofi Pasteur, a Sanofi Company 401
Testing effectiveness (Phase 2)Study completedNCT00976469What this trial is testingA/H1N1 Immunogenicity and Safety in Infants, Children and AdolescentsWho this might be right forInfluenzaPandemic Influenza Alachua Government Services, Inc. 400
Post-approval studies (Phase 4)Study completedNCT01000831What this trial is testingRapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young ChildrenWho this might be right forInfluenza University of British Columbia 167
Large-scale testing (Phase 3)Ended earlyNCT01160237What this trial is testingStudy to Evaluate the Immune Response and the Safety of Fluarix TM/ Influsplit SSW® 2010/2011 or Pandemrix TMWho this might be right forInfluenza GlaxoSmithKline 7
Early research (Phase 1)Study completedNCT01111968What this trial is testingEvaluation of Pandemic Influenza A (H1N1)Candidate VaccinesWho this might be right forInfluenza Butantan Institute 266
Early research (Phase 1)Study completedNCT01855945What this trial is testingSafety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.Who this might be right forProphylaxis of A/H3N2v Influenza Novartis Vaccines 627
Testing effectiveness (Phase 2)Study completedNCT00956202What this trial is testingInactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 YearsWho this might be right forInfluenzaSwine-origin A/H1N1 Influenza Sanofi Pasteur, a Sanofi Company 303
Large-scale testing (Phase 3)Study completedNCT00972816What this trial is testingSafety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Children (3 to < 9 Years)Who this might be right forInfluenza Novartis Vaccines 1,357
Large-scale testing (Phase 3)Ended earlyNCT00979667What this trial is testingA Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza InfectionWho this might be right forUpper Respiratory Tract InfectionInfluenza Chinese University of Hong Kong 4
Testing effectiveness (Phase 2)Study completedNCT00943488What this trial is testingCSL H1N1 Influenza Vaccine Administered at Two Dose Levels in Adult and Elderly PopulationsWho this might be right forInfluenza National Institute of Allergy and Infectious Diseases (NIAID) 408
Post-approval studies (Phase 4)Study completedNCT01047202What this trial is testingSinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months InfantsWho this might be right forInfluenza Sinovac Biotech Co., Ltd 310